Authors:
Kiran Pulidindi, Kavita Yadav
Download free PDF
Citric Acid & Lactic Acid Market Size & Share 2026-2035
Report ID: GMI16288
|
Published Date: September 2026
|
Report Format: PDF/Excel/Dashboard/Platform
Explore Our Licensing Options:
Immediate Delivery Available
Citric Acid & Lactic Acid Market
Get a free sample of this report
What are you hoping to find?
Your PDF is on its way. Tell us little about your research goal, and we'll help you find the most relevant market insights.
Citric Acid and Lactic Acid for Food Market Size
The global citric acid and lactic acid for food market is valued at USD 11.6 billion in 2026 and is projected to reach USD 18.2 billion by 2035, representing a 5.1% CAGR for 2026-2035. The historic path should not be read as a simple demand curve: Chinese citric-acid export pricing weakened during 2024 while shipments increased, separating revenue pressure from continuing consumption growth.
Citric Acid & Lactic Acid Market Key Takeaways
Market Leader: Jungbunzlauer Suisse AG led with over 11.4% market share in 2025.
Leading Players: Top 5 players in this market include Jungbunzlauer Suisse AG, Corbion N.V., RZBC Group Co., Ltd., Archer Daniels Midland (ADM), Cargill, Incorporated, which collectively held a market share of 47.7% in 2025.
Citric acid remains the larger product franchise, at USD 7,300 million in 2025, while lactic acid represented approximately USD 3,730 million. Their common fermentation base links feedstock economics, but their demand profiles differ. Citric acid derives resilience from its use as an acidulant, buffer, sequestrant, and flavor-management ingredient across food systems. Lactic acid couples food preservation with higher-value pharmaceutical, personal-care, and polylactic-acid pathways. Commercial citric acid is predominantly made by Aspergillus niger fermentation, while lactic acid is principally produced through bacterial fermentation [1]PMC/NCBI, Citric Acid: Properties, Microbial Production, and Applications in Industries. pmc.ncbi.nlm.nih.gov.
China's concentration of citric-acid production makes its starch, energy, inventory, and export-pricing conditions relevant well beyond Asia Pacific. The result is a two-speed market: food-grade citric acid can face abrupt price competition, whereas qualified lactic acid and high-purity acid grades are less interchangeable because formulation performance, optical properties, customer validation, and regulatory documentation matter alongside price.
GMI Analyst View
The 5.1% forecast is best understood as a recovery in revenue quality rather than a continuation of the pricing conditions that shaped 2022-2024. Positive consumption growth during a period of lower Chinese export prices indicates that acid demand remained embedded in formulations, even as realized revenue was compressed. Pricing stabilization, rather than a speculative demand surge, is therefore central to the outlook.
The principal strategic divide is between scale-sensitive citric acid and application-led lactic acid. Suppliers exposed mainly to undifferentiated citric-acid trade remain vulnerable to China-led price resets. Those able to supply audited food, pharmaceutical, and specialty grades can convert formulation approval and documentation into more durable customer relationships. Lactic acid has an additional route to value creation through PLA and derivatives, although that opportunity depends on downstream project execution and packaging demand rather than on food consumption alone.
Key Drivers
Expanding demand from the food and beverage industry
Food and beverages, valued at USD 5,600 million in 2025, is the largest application. Citric acid's broad functional permission is commercially significant: Codex lists INS 330 for acidification, sequestration, color retention, and antioxidant use across food categories [2]FAO Codex Alimentarius, Food Additive Details for Citric acid (INS 330). fao.org. Lactic acid, INS 270, provides acidification and preservation functionality in fermented dairy, bakery, meat, and prepared-food systems. These functions are embedded in production specifications, so demand is supported by recurring formulation use rather than discretionary ingredient adoption.
Regulatory familiarity also reduces reformulation friction. When a processor serves several markets, ingredients with established Codex recognition can simplify recipe harmonization and supplier qualification. That favors reliable, documented supply over the lowest spot price, particularly where a food manufacturer must protect pH control, microbial stability, taste, and shelf-life performance simultaneously.
Growing preference for sustainable and bio-based materials
Lactic acid's role as a PLA precursor extends the market beyond conventional food demand. European Bioplastics expects PLA and PHA capacity to grow over the coming years, while packaging accounts for 41.3% of the bioplastics application mix [3]European Bioplastics e.V., Market data, bioplastics production capacities and application segments 2025. european-bioplastics.org. The commercial effect is upstream: a packaging converter's switch to PLA can create demand for lactic-acid derivatives without relying on food-formulation growth.
Citric acid has a narrower but technically credible packaging role. Research on thermoplastic starch/PLA blends shows that citric-acid modification can affect blend compatibility and functional properties. This does not make citric acid a direct substitute for lactic acid in PLA production; it creates a separate specialty-material route where technical performance, not bulk acid demand, determines value.
Rising utilization in pharmaceutical and personal care applications
Citric acid is used as a buffer, acidulant, chelating agent, and effervescent component in pharmaceutical formulations. In personal care, citric and lactic acids serve pH-adjustment and alpha-hydroxy-acid functions. These uses reward consistent purity, traceability, and validated documentation, raising the economic importance of grade control relative to commodity food applications.
The practical implication is that qualification time becomes a competitive barrier. A producer that can maintain repeatable specifications may secure higher-value demand, but it must also absorb the cost of validation, audit readiness, and change control. The opportunity is therefore strongest for suppliers with established quality systems rather than for capacity added solely to pursue price-led growth.
Key Restraints
Volatility in raw material availability and costs
Fermentation economics expose producers to carbohydrate feedstock, utilities, and conversion efficiency. A techno-economic assessment of corn-based lactic acid identifies feedstock as a major cost element. Citric-acid producers face a related sensitivity to starch substrates. Integrated agricultural sourcing can soften this exposure, whereas non-integrated suppliers must manage cost swings through contracts, inventory, formulation mix, or price adjustments.
The pressure is amplified by Chinese export pricing. Lower export prices can support downstream consumption but compress margins for producers outside the lowest-cost supply clusters. This creates a procurement paradox for buyers: competitive spot prices may lower immediate input costs, yet an overly narrow supply base can increase exposure to disruptions, specification changes, or later price reversals.
Regulatory and compliance challenges
Food-additive acceptance does not eliminate compliance work. EFSA's re-evaluation of citric and lactic acids found no safety concern at reported uses and use levels, but the review underscores the need for evidence on identity, specifications, exposure, and intended use. Manufacturers selling across food, pharmaceutical, and cosmetic channels must maintain distinct quality and documentation regimes even when the underlying molecule is the same.
New feedstocks and production pathways add a second constraint. A fermentation innovation can improve raw-material flexibility, but commercial adoption still requires customer qualification and, where applicable, regulatory assessment. That slows the conversion of laboratory advances into revenue, particularly for pharmaceutical and food applications where a supply change can trigger a formal requalification process.
GMI Analyst View
Demand drivers and restraints act on different parts of the value chain. Food formulation, PLA conversion, and specialty-grade demand support consumption, while feedstock volatility and China-led citric-acid pricing determine how much of that demand converts into producer revenue. The distinction matters because a lower-cost market can still be a poor margin environment for non-integrated suppliers.
This favors portfolio and operating flexibility over undifferentiated scale. Suppliers that can redirect production toward validated grades, contract feedstocks, and serve food alongside pharmaceutical or specialty customers are better placed to absorb price cycles. Conversely, a buyer dependent on commodity imports may obtain short-term savings but give up supply optionality. Compliance raises entry costs, yet it can also protect incumbents whose documentation and audit performance have already been accepted by customers.
Citric Acid and Lactic Acid for Food Market Segment Analysis
By product type
Citric acid is the leading product segment at USD 7,300 million in 2025 and is expected to grow at a 3.5% CAGR through 2035. Its scale reflects extensive food use and a mature fermentation model. That maturity is commercially double-edged: it supports dependable availability and low unit cost, but it also makes citric acid especially susceptible to price competition where grades are interchangeable.
Lactic acid, at approximately USD 3,730 million, has a smaller base but a broader set of differentiated routes to demand. Fermentation can yield product characteristics relevant to food, pharmaceutical, and polymer applications. Its growth case depends on the ability of suppliers and converters to monetize those characteristics through approved applications and downstream PLA demand, rather than treating lactic acid as a simple food acidulant.
By grade and form
Food grade, at USD 5,700 million, is the largest grade because food and beverage is the principal application. Pharmaceutical and cosmetic grades carry stricter purity, batch-control, and traceability expectations, which can raise the value of qualified supply. Industrial and technical grades remain relevant in cleaning, textile, and process uses, but compete more directly on functional performance and cost.
Anhydrous powder, valued at USD 4,700 million, is the largest form. Its utility in dry beverage mixes, powders, and moisture-sensitive formulations makes water content a product-performance issue rather than a packaging detail. Liquid solutions suit high-throughput operations that use controlled dosing; monohydrate and granulated products serve applications requiring specific crystal form, handling, or flow behavior.
By production process and application
Fermentation-based production accounted for approximately USD 10,800 million in 2025, or about 98% of market revenue, compared with approximately USD 230 million for chemical synthesis. The dominance reflects technical fit as well as economics: fermentation is aligned with food and bio-based positioning, whereas chemical routes can be disadvantaged in applications requiring particular lactic-acid optical characteristics.
Food and beverages led applications at USD 5,600 million in 2025. Pharmaceuticals and personal care offer a higher specification threshold; bioplastics and biodegradable packaging provide the clearest non-food expansion route for lactic acid. Detergents and household cleaners contributed USD 957 million in 2022, supported by citric acid's chelating and descaling functions. Textile, leather, and other industrial uses contributed USD 286 million in 2022, providing a diversified but comparatively mature demand base.
GMI Analyst View
Segment economics are governed less by the identity of the molecule than by the cost of changing supplier or grade. Commodity citric acid can be substituted relatively easily when specifications are standard. Pharmaceutical, cosmetic, and specialty-form acids are protected by qualification, batch consistency, and application performance. That makes premiumization a matter of operational capability, not merely a change in product mix.
Fermentation's near-total revenue share also has strategic consequences. It ties both acids to agricultural feedstocks, but gives suppliers a credible bio-based platform for customers seeking cleaner-label ingredients and lower-fossil-carbon material routes. Lactic acid benefits disproportionately where PLA projects reach commercial operation; citric acid's more dependable value lies in its broad installed base across food, cleaning, and formulation chemistry.
Citric Acid and Lactic Acid for Food Market Regional Analysis
North America
North America is the largest regional market, valued at USD 3,700 million in 2025 and projected to reach USD 5,800 million by 2035. The United States accounted for USD 2,900 million in 2025. Food processing, pharmaceutical formulation, and demand for validated specialty ingredients underpin the regional mix. The cancellation of ADM and LG Chem's planned lactic-acid and PLA ventures in July 2024 removed a proposed domestic supply addition after construction costs rose sharply [4]Archer Daniels Midland Company, ADM, LG Chem Announce That Lactic Acid, Polylactic Acid Projects Will Not Move Forward. investors.adm.com.
Europe
Europe is valued at USD 2,900 million in 2025 and is projected to reach USD 4,600 million by 2035. Its opportunity is concentrated in regulated food supply, pharmaceutical-grade demand, and bio-based materials. Futerro and Galactic announced a May 2025 partnership in Normandy to convert lactic acid into derivatives for agri-food and green-chemistry uses [5]Futerro, Green chemistry: a partnership between Futerro and Galactic to develop the potential of lactic acid on the European market. futerro.com. This links European demand-pull policies and downstream material investment with an upstream route for lactic acid, although project execution remains decisive.
Asia Pacific
Asia Pacific is the fastest-growing region, rising from USD 3,000 million in 2025 to USD 5,500 million by 2035. It combines expanding food consumption with a major citric-acid supply base and growing lactic-acid infrastructure. Corbion completed the startup of its Thailand lactic-acid plant in 2024, strengthening the region's role in food ingredients and PLA-related supply chains. The region's scale is an advantage for cost and proximity, but it also intensifies competitive pressure in standard citric-acid grades.
Latin America
Latin America is valued at USD 809 million in 2025 and is expected to reach approximately USD 1,350 million by 2035. Brazil and Mexico provide the largest food-processing demand pools. RZBC's status as the only Chinese citric-acid producer exempt from Brazilian anti-dumping duties gives it a specific route to compete in a market where trade measures can otherwise alter delivered economics. Currency movements and import exposure remain material constraints for buyers and distributors.
Middle East and Africa
The Middle East and Africa market is valued at USD 552 million in 2025 and projected to reach USD 908 million by 2035. Growth follows food-industry formalization, urban consumption, and expanding processing capacity, while regional import dependence keeps logistics and supplier reliability commercially important. The Gulf food and pharmaceutical sectors and South Africa's established food-and-beverage base create distinct demand nodes rather than a uniform regional market.
GMI Analyst View
Regional positioning turns supply resilience into a source of competitive differentiation. North America has large demand but less near-term lactic-acid supply optionality following the ADM-LG Chem cancellation. Europe can support premium and derivative-oriented demand, but must balance domestic specialization against imported commodity citric acid. Asia Pacific pairs demand growth with the strongest production platform, allowing it to influence global price formation as well as regional availability.
Latin America and the Middle East and Africa are primarily market-access stories. In Latin America, trade treatment can materially change a supplier's competitiveness, as demonstrated by RZBC's Brazil exemption. In the Middle East and Africa, the commercial challenge is securing dependable imported supply as local processing demand develops. Across regions, suppliers with diversified plants, grade flexibility, and qualified distribution networks are better positioned than producers competing solely on nominal acid price.
Citric Acid and Lactic Acid for Food Market Share & Competitive Landscape
The market is moderately concentrated: the five largest companies held 47.7% of revenue in 2025, and Jungbunzlauer Suisse AG led with 11.4%. Competition combines global fermentation specialists, integrated agricultural processors, Chinese citric-acid manufacturers, and regional distributors. The decisive capabilities are not identical across competitors: citric-acid scale and feedstock access matter in commodity channels, while lactic-acid derivatives, quality systems, and customer qualification matter in specialty channels.
Jungbunzlauer Suisse AG supplies both acids and operates plants in Austria, France, Germany, and Canada. Its product range includes citric acid, lactic acid, and solution formats, and its documented GMP capability supports pharmaceutical applications. Serving more than 130 countries, it is positioned to convert multi-site production and qualified grades into resilience for food and life-science customers.
Corbion N.V. is a lactic-acid specialist with food, pharmaceutical, and PLA exposure. Its FY2024 sales were €1,288.1 million and adjusted EBITDA was €175.0 million, up 25% year on year. The company commissioned its Thailand lactic-acid plant during 2024 and divested its Emulsifiers business in April 2024 for $362 million, concentrating the portfolio on fermentation-based ingredients.
RZBC Group Co., Ltd. is a Shandong-based citric-acid specialist with a full citrate-salt range. Its Brazilian anti-dumping exemption is a distinctive access advantage. Archer Daniels Midland Company is confirmed in citric acid; its active lactic-acid capability should not be assumed after the cancelled GreenWise Lactic venture. Cargill, Incorporated is confirmed in both acids and competes through fermentation, agricultural sourcing, and global supply-chain reach.
Galactic S.A. focuses on lactic acid and derivatives, including a China joint venture with BBCA Biochemical. COFCO Biotechnology Co., Ltd. participates in both acids within the COFCO group. Citribel N.V. provides European citric-acid supply to food, pharmaceutical, and industrial customers. TTCA Co., Ltd. supplies citric acid and citrate grades for international markets. Gadot Biochemical Industries Ltd. is an Israel-based citric-acid specialist with distribution-oriented reach in the Middle East and global markets.
Recent Industry Developments
Need a specific section of this report?
Purchase regional analysis, country-level analysis, company profiles, or any other segment-level insights separately
based on your research needs.
Frequently Asked Questions (FAQs):
Research methodology, data sources & validation process
This report draws on a structured research process built around direct industry conversations, proprietary modelling, and rigorous cross-validation and not just desk research.
Our 6-step research process
1. Research design & analyst oversight
At GMI, our research methodology is built on a foundation of human expertise, rigorous validation, and complete transparency. Every insight, trend analysis, and forecast in our reports is developed by experienced analysts who understand the nuances of your market.
Our approach integrates extensive primary research through direct engagement with industry participants and experts, complemented by comprehensive secondary research from verified global sources. We apply quantified impact analysis to deliver dependable forecasts, while maintaining complete traceability from original data sources to final insights.
2. Primary research
Primary research forms the backbone of our methodology, contributing nearly 80% to overall insights. It involves direct engagement with industry participants to ensure accuracy and depth in analysis. Our structured interview program covers regional and global markets, with inputs from C-suite executives, directors, and subject matter experts. These interactions provide strategic, operational, and technical perspectives, enabling well-rounded insights and reliable market forecasts.
3. Data mining & market analysis
Data mining is a key part of our research process, contributing nearly 20% to the overall methodology. It involves analysing market structure, identifying industry trends, and assessing macroeconomic factors through revenue share analysis of major players. Relevant data is collected from both paid and unpaid sources to build a reliable database. This information is then integrated to support primary research and market sizing, with validation from key stakeholders such as distributors, manufacturers, and associations.
4. Market sizing
Our market sizing is built on a bottom-up approach, starting with company revenue data gathered directly through primary interviews, alongside production volume figures from manufacturers and installation or deployment statistics. These inputs are then pieced together across regional markets to arrive at a global estimate that stays grounded in actual industry activity.
5. Forecast model & key assumptions
Every forecast includes explicit documentation of:
✓ Key growth drivers and their assumed impact
✓ Restraining factors and mitigation scenarios
✓ Regulatory assumptions and policy change risk
✓ Technology adoption curve parameter
✓ Macroeconomic assumptions (GDP growth, inflation, currency)
✓ Competitive dynamics and market entry/exit expectations
6. Validation & quality assurance
The final stages involve human validation, where domain experts manually review filtered data to identify nuances and contextual errors that automated systems might miss. This expert review adds a critical layer of quality assurance, ensuring data aligns with research objectives and domain-specific standards.
Our triple-layer validation process ensures maximum data reliability:
✓ Statistical Validation
✓ Expert Validation
✓ Market Reality Check
Trust & credibility
Verified data sources
Trade publications
Industry journals, trade publications, and specialized media.
Industry databases
Proprietary and third-party market databases
Regulatory filings
Government procurement records and policy documents
Academic research
University studies and specialist institution reports
Company reports
Annual reports, investor presentations, and filings
Expert interviews
C-suite, procurement leads, and technical specialists
GMI archive
13,000+ published studies across 20+ industry verticals
Trade data
Import/export volumes, HS codes, and customs records
Parameters studied & evaluated
Every data point in this report is validated through primary interviews, true bottom-up modelling, and rigorous cross-checks. Read about our research process →